Who
In numbers
- Trades disclosed
- 16
- Buys
- 2
- Sells
- 0
- Bought
- $7,800
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 9 Sep 2019
- Last trade
- 12 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Oct 2026filed 13 Oct 2026 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code D | —166 at $0.00 | filing |
| 12 Oct 2026filed 13 Oct 2026 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code D | —41 at $0.00 | filing |
| 12 Oct 2026filed 13 Oct 2026 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code D | —166 at $0.00 | filing |
| 12 Oct 2026filed 13 Oct 2026 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code D | —208 at $0.00 | filing |
| 12 Oct 2026filed 13 Oct 2026 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code D | —333 at $0.00 | filing |
| 11 Dec 2025filed 12 Dec 2025 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 12 Dec 2024filed 13 Dec 2024 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 8 Dec 2023filed 8 Dec 2023 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 8 Dec 2022filed 9 Dec 2022 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 21 Jan 2022filed 21 Jan 2022 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 15 Dec 2021filed 15 Dec 2021 | SNGX SoligenixBiotechnology | SEC FORM 4 Bought | $7001,000 at $0.70 | filing |
| 14 Dec 2021filed 15 Dec 2021 | SNGX SoligenixBiotechnology | SEC FORM 4 Bought | $7,10010,000 at $0.71 | filing |
| 9 Dec 2021filed 10 Dec 2021 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 10 Dec 2020filed 11 Dec 2020 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 12 Dec 2019filed 13 Dec 2019 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 9 Sep 2019filed 11 Sep 2019 | SNGX Soligenixoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
Reviewing Soligenix (NASDAQ:SNGX) and Curis (NASDAQ:CRIS)SNGX · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name Jonathan L. Guarino; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.